Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Foot and Mouth Disease Vaccines Market

Foot and Mouth Disease Vaccines Market Share

Report ID: GMI11014
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Foot and Mouth Disease Vaccines Market Share

The market industry is characterized by the presence of several established and emerging players that offer a variety of treatments across the globe. The market players compete based on factors such as treatment quality, innovation, regulatory compliance, customer service, and pricing strategies.

Foot and Mouth Disease Vaccines Market Companies

Prominent players operating in the market industry include:

Biogénesis Bagó
Biovet Private Ltd
Brilliant Bio Pharma Private Limited
BVI
C.H. Boehringer Sohn AG & Co. KG
Ceva Santé Animale
Indian Immunologicals Ltd.
Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
Kenya Veterinary Vaccines Production Institute
Merck & Co., Inc.
MEVAC

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The foot and mouth disease vaccines industry size was valued at USD 2.5 billion in 2023 and is anticipated to witness CAGR 7.7% CAGR from 2024 to 2032 driven by the rising prevalence of foot and mouth disease outbreaks, and substantial commercialization of livestock products.

The conventional vaccines type segment in the foot and mouth disease (FMD) vaccines market recorded 83.9% share in 2023 due to proven track record of success in various regions, particularly in endemic areas where the disease poses a constant threat.

North America FMD vaccines industry is predicted to witness 6.7% CAGR through 2032 led by the need for proactive approach towards safeguarding livestock and the agricultural sector

Biogénesis Bagó, Biovet Private Ltd, C.H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Indian Immunologicals Ltd., Merck & Co., Inc. and Inner Mongolia Biwei Antai Biotechnology Co., Ltd.